Analyst Profile

Followed by 25 followers
.
Rachel Vatnsdal

Rachel Vatnsdal

J.P. Morgan
Wall Street Analyst
#2,439 out of 8,141 Wall Street Analysts
#5,297 out of 24,284 experts

Success Rate

43%
12 out of 28 transactions made a profit

Average Return

+10.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Rachel Vatnsdal's trades since 2020 and holding each position for 1 Year would result in 42.86% of your transactions generating a profit, with an average return of 10.6% per rating.

Stock Rating Distribution

39Ratings
56.41% Buy
25.64% Hold
17.95% Sell
Distribution of Rachel Vatnsdal's ratings

Additional Information

Main Sector:General
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
CareDx Inc
(CDNA)
Rating:Buy
Date:May 01, 2020 - May 01, 2021
Return:+194.40%
The most profitable rating made by Rachel Vatnsdal

Rachel Vatnsdal's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
OncoCyte
Apr 30, 2020
Buy
Reiterated
$5.40
(1100.00% Upside)
1Ratings
100%
+90.30%
CareDx
May 01, 2020
Buy
Reiterated
$54.00
(347.76% Upside)
1Ratings
100%
+194.40%
Standard BioTools
May 10, 2020
Buy
Reiterated
$9.00
(561.76% Upside)
1Ratings
100%
+10.60%
Natera
May 14, 2020
Buy
Reiterated
$56.00
(50.58% Upside)
1Ratings
100%
+106.50%
Accelerate Diagnostics
Aug 10, 2020
Buy
Reiterated
$18.00
(1992.05% Upside)
1Ratings
0%
-58.90%
Bruker
May 04, 2022
Hold
Reiterated
$65.00
(-0.21% Downside)
1Ratings
0.00%
Quest Diagnostics
Jul 22, 2022
Hold
Reiterated
$145.00
(-2.69% Downside)
1Ratings
0.00%
Rapid Micro Biosystems
Sep 06, 2022
Hold
Downgraded
6Ratings
0%
-10.50%
Danaher
Oct 21, 2022
Buy
Reiterated
$315.00
(21.61% Upside)
3Ratings
33%
-1.00%
Thermo Fisher
Oct 27, 2022
Buy
Reiterated
$650.00
(20.43% Upside)
2Ratings
50%
+0.70%
List of latest recommendations made by Rachel Vatnsdal. Click to expand and see Rachel Vatnsdal's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >